Profitability
Dividends
Income Statement
Balance Sheet
Cash Flow Statement
Symbol Frequently Asked Questions

Liminatus Pharma, Inc. Class A Common Stock (LIMN) can sell. Click on Rating Page for detail.

The price of Liminatus Pharma, Inc. Class A Common Stock (LIMN) is 23.98 and it was updated on 2025-06-26 02:01:22.

Currently Liminatus Pharma, Inc. Class A Common Stock (LIMN) is in undervalued.

SEC Filings
SEC Filings
Unlock
LIMN Ratings Summary
LIMN Quant Ranking